By Priscila Mayumi Kashiwabara
10 de April de 2025
Life Sciences Brazil Global Guide 2025 | Chambers & Partners
We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2025 Global Practice Guide!
Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2025 guide for Brazil. This guide outlines the regulatory framework for pharmaceuticals and medical devices, detailing legislation, regulatory bodies, and procedures for approvals and appeals. It covers categorization, clinical trials, marketing authorizations, and ongoing obligations.
The guide also emphasizes ANVISA’s role in regulation, stringent requirements for biologics, and procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations, and measures against counterfeit products.
Click here to read the full article: https://lnkd.in/dbU5yrvD.
Share:
Last by Priscila Mayumi Kashiwabara
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents
29 de May de 2026
Kasznar Leonardos has been ranked by IAM Patent 1000
It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the … Kasznar Leonardos has been ranked by IAM Patent 1000
17 de June de 2025
Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation
On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International … Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation